Clinical trial
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate The Efficacy and Safety of Reconyl in Acute Cough Treatment
NCT07420491 is registered in ClinicalTrials.gov with Dexa Medica Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate The Efficacy and Safety of Reconyl in Acute Cough Treatment
- Lead sponsor
- Dexa Medica Group
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- June 26, 2025
- Completion date
- October 3, 2025
- Enrollment
- 144 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.